Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Transcriptomics: mRNA and alternative splicing.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.

Pages